Head & Neck Cancer Drugs Market Insights and Growth by 2031
Head & neck cancer is especially common in regions having high alcohol and tobacco intake, and the most common type is squamous cell carcinoma. About 9 out of 10 head and neck cancers begin inside squamous cells. Chemotherapy drugs commonly used to treat head and neck cancers are cisplatin, carboplatin, and docetaxel. The EGFR-targeted drug, in combination with chemotherapy or radiation therapy for head and neck cancers, such as laryngeal or hypopharyngeal cancer, is a targeted therapy drug for head & neck cancer.
MARKET SCOPE
The "Head & neck cancer drugs market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of head & neck cancer drugs market with detailed market segmentation by of product, labeling method, application. The head & neck cancer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in head & neck cancer drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- n the basis of product type, the market is segmented into PD Inhibitors, Microtubule Inhibitors, EGFR Inhibitors.
- n the basis of application, the market is segmented into Surgery, Radiation therapy, Chemotherapy, Immunotherapy.
MARKET DYNAMICS
Drivers:
- Rise in demand for combination therapy for the management of head & neck cancer.
- Growth in the number of R&D activities to develop ideal therapeutic.
- Growth in the number of cigarette smoking, alcohol & tobacco consumption.
Restraints:
- High cost of therapeutic drugs.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the head & neck cancer drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The head & neck cancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting head & neck cancer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting head & neck cancer drugs market in these regions.
IMPACT OF COVID-19 ON HEAD AND NECK CANCER DRUG MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the head & neck cancer drugs market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the head & neck cancer drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The head & neck cancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting head & neck cancer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting head & neck cancer drugs market in these regions.
IMPACT OF COVID-19 ON HEAD AND NECK CANCER DRUG MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the head & neck cancer drugs market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the head & neck cancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from head & neck cancer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for head & neck cancer drugs market in the global market. Below mentioned is the list of few companies engaged in the head & neck cancer drugs market.
The report also includes the profiles of key players in head & neck cancer drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- AstraZeneca Plc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
- Fresenius Medical Care AG and Co. KGaA
- Merck and Co., Inc.
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Limited
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Head And Neck Cancer Drugs Market - By Product
1.3.2 Head And Neck Cancer Drugs Market - By Application
1.3.3 Head And Neck Cancer Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEAD AND NECK CANCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEAD AND NECK CANCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEAD AND NECK CANCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEAD AND NECK CANCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. HEAD AND NECK CANCER DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. HEAD AND NECK CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PD INHIBITORS
7.3.1. Overview
7.3.2. PD Inhibitors Market Forecast and Analysis
7.4. MICROTUBULE INHIBITORS
7.4.1. Overview
7.4.2. Microtubule Inhibitors Market Forecast and Analysis
7.5. EGFR INHIBITORS
7.5.1. Overview
7.5.2. EGFR Inhibitors Market Forecast and Analysis
8. HEAD AND NECK CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SURGERY
8.3.1. Overview
8.3.2. Surgery Market Forecast and Analysis
8.4. RADIATION THERAPY
8.4.1. Overview
8.4.2. Radiation Therapy Market Forecast and Analysis
8.5. CHEMOTHERAPY
8.5.1. Overview
8.5.2. Chemotherapy Market Forecast and Analysis
8.6. IMMUNOTHERAPY
8.6.1. Overview
8.6.2. Immunotherapy Market Forecast and Analysis
9. HEAD AND NECK CANCER DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Head And Neck Cancer Drugs Market Overview
9.1.2 North America Head And Neck Cancer Drugs Market Forecasts and Analysis
9.1.3 North America Head And Neck Cancer Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Head And Neck Cancer Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Head And Neck Cancer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Head And Neck Cancer Drugs Market
9.1.5.1.1 United States Head And Neck Cancer Drugs Market by Product
9.1.5.1.2 United States Head And Neck Cancer Drugs Market by Application
9.1.5.2 Canada Head And Neck Cancer Drugs Market
9.1.5.2.1 Canada Head And Neck Cancer Drugs Market by Product
9.1.5.2.2 Canada Head And Neck Cancer Drugs Market by Application
9.1.5.3 Mexico Head And Neck Cancer Drugs Market
9.1.5.3.1 Mexico Head And Neck Cancer Drugs Market by Product
9.1.5.3.2 Mexico Head And Neck Cancer Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Head And Neck Cancer Drugs Market Overview
9.2.2 Europe Head And Neck Cancer Drugs Market Forecasts and Analysis
9.2.3 Europe Head And Neck Cancer Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Head And Neck Cancer Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Head And Neck Cancer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Head And Neck Cancer Drugs Market
9.2.5.1.1 Germany Head And Neck Cancer Drugs Market by Product
9.2.5.1.2 Germany Head And Neck Cancer Drugs Market by Application
9.2.5.2 France Head And Neck Cancer Drugs Market
9.2.5.2.1 France Head And Neck Cancer Drugs Market by Product
9.2.5.2.2 France Head And Neck Cancer Drugs Market by Application
9.2.5.3 Italy Head And Neck Cancer Drugs Market
9.2.5.3.1 Italy Head And Neck Cancer Drugs Market by Product
9.2.5.3.2 Italy Head And Neck Cancer Drugs Market by Application
9.2.5.4 Spain Head And Neck Cancer Drugs Market
9.2.5.4.1 Spain Head And Neck Cancer Drugs Market by Product
9.2.5.4.2 Spain Head And Neck Cancer Drugs Market by Application
9.2.5.5 United Kingdom Head And Neck Cancer Drugs Market
9.2.5.5.1 United Kingdom Head And Neck Cancer Drugs Market by Product
9.2.5.5.2 United Kingdom Head And Neck Cancer Drugs Market by Application
9.2.5.6 Rest of Europe Head And Neck Cancer Drugs Market
9.2.5.6.1 Rest of Europe Head And Neck Cancer Drugs Market by Product
9.2.5.6.2 Rest of Europe Head And Neck Cancer Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Head And Neck Cancer Drugs Market Overview
9.3.2 Asia-Pacific Head And Neck Cancer Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Head And Neck Cancer Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Head And Neck Cancer Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Head And Neck Cancer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Head And Neck Cancer Drugs Market
9.3.5.1.1 Australia Head And Neck Cancer Drugs Market by Product
9.3.5.1.2 Australia Head And Neck Cancer Drugs Market by Application
9.3.5.2 China Head And Neck Cancer Drugs Market
9.3.5.2.1 China Head And Neck Cancer Drugs Market by Product
9.3.5.2.2 China Head And Neck Cancer Drugs Market by Application
9.3.5.3 India Head And Neck Cancer Drugs Market
9.3.5.3.1 India Head And Neck Cancer Drugs Market by Product
9.3.5.3.2 India Head And Neck Cancer Drugs Market by Application
9.3.5.4 Japan Head And Neck Cancer Drugs Market
9.3.5.4.1 Japan Head And Neck Cancer Drugs Market by Product
9.3.5.4.2 Japan Head And Neck Cancer Drugs Market by Application
9.3.5.5 South Korea Head And Neck Cancer Drugs Market
9.3.5.5.1 South Korea Head And Neck Cancer Drugs Market by Product
9.3.5.5.2 South Korea Head And Neck Cancer Drugs Market by Application
9.3.5.6 Rest of Asia-Pacific Head And Neck Cancer Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Head And Neck Cancer Drugs Market by Product
9.3.5.6.2 Rest of Asia-Pacific Head And Neck Cancer Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Head And Neck Cancer Drugs Market Overview
9.4.2 Middle East and Africa Head And Neck Cancer Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Head And Neck Cancer Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Head And Neck Cancer Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Head And Neck Cancer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Head And Neck Cancer Drugs Market
9.4.5.1.1 South Africa Head And Neck Cancer Drugs Market by Product
9.4.5.1.2 South Africa Head And Neck Cancer Drugs Market by Application
9.4.5.2 Saudi Arabia Head And Neck Cancer Drugs Market
9.4.5.2.1 Saudi Arabia Head And Neck Cancer Drugs Market by Product
9.4.5.2.2 Saudi Arabia Head And Neck Cancer Drugs Market by Application
9.4.5.3 U.A.E Head And Neck Cancer Drugs Market
9.4.5.3.1 U.A.E Head And Neck Cancer Drugs Market by Product
9.4.5.3.2 U.A.E Head And Neck Cancer Drugs Market by Application
9.4.5.4 Rest of Middle East and Africa Head And Neck Cancer Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Head And Neck Cancer Drugs Market by Product
9.4.5.4.2 Rest of Middle East and Africa Head And Neck Cancer Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Head And Neck Cancer Drugs Market Overview
9.5.2 South and Central America Head And Neck Cancer Drugs Market Forecasts and Analysis
9.5.3 South and Central America Head And Neck Cancer Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Head And Neck Cancer Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Head And Neck Cancer Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Head And Neck Cancer Drugs Market
9.5.5.1.1 Brazil Head And Neck Cancer Drugs Market by Product
9.5.5.1.2 Brazil Head And Neck Cancer Drugs Market by Application
9.5.5.2 Argentina Head And Neck Cancer Drugs Market
9.5.5.2.1 Argentina Head And Neck Cancer Drugs Market by Product
9.5.5.2.2 Argentina Head And Neck Cancer Drugs Market by Application
9.5.5.3 Rest of South and Central America Head And Neck Cancer Drugs Market
9.5.5.3.1 Rest of South and Central America Head And Neck Cancer Drugs Market by Product
9.5.5.3.2 Rest of South and Central America Head And Neck Cancer Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HEAD AND NECK CANCER DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HEAD AND NECK CANCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRISTOL-MYERS SQUIBB COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD. (GENENTECH, INC.)
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FRESENIUS MEDICAL CARE AG AND CO. KGAA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. AstraZeneca Plc.
2. Bristol-Myers Squibb Company
3. Eli Lilly and Company
4. F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
5. Fresenius Medical Care AG and Co. KGaA
6. Merck and Co., Inc.
7. Pfizer Inc.
8. Sanofi
9. Sun Pharmaceutical Industries Ltd.
10. Teva Pharmaceutical Industries Limited
11. Boston Biomedical, Inc.
12. AB Science SA
13. Acceleron Pharma
14. Bayer AG
15. AbbVie Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For